title: [New therapies in thyroid cancer].
authors.affiliation: Sección Endocrinología y Nutrición, Hospital General Universitario Alicante, Alicante, España. Electronic address: pedrolopezmondejar@hotmail.com.
authors.forename: Pedro
authors.initials: P
authors.lastname: López Mondéjar
authors.affiliation: Departamento de Endocrinología y Nutrición, Clínica Universidad de Navarra, Pamplona, España; Instituto de investigación en la Salud de Navarra (IdiSNA).
authors.forename: Juan Carlos
authors.initials: JC
authors.lastname: Galofré
mesh_terms: D018263:Adenocarcinoma, Follicular / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000378:metabolism; D002277:Carcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D002291:Carcinoma, Papillary; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009367:Neoplasm Staging; D018579:Patient Selection; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D000077273:Thyroid Cancer, Papillary; D013964:Thyroid Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D047428:Protein Kinase Inhibitors; D011505:Protein-Tyrosine Kinases